Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Cryptosporidium parvum | inosine-5-monophosphate dehydrogenase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | GMP reductase | 0.0134 | 0 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.6653 | 1 | 1 |
Loa Loa (eye worm) | IMP dehydrogenase 1 | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | GMP reductase | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0864 | 0.112 | 0.5 |
Leishmania major | guanosine monophosphate reductase | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0864 | 0.112 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.6653 | 1 | 1 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) | 0.0134 | 0 | 0.5 |
Schistosoma mansoni | inosine-5-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.6653 | 1 | 1 |
Trypanosoma brucei | inosine-5'-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.6653 | 1 | 1 |
Echinococcus multilocularis | inosine 5' monophosphate dehydrogenase 2 | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0864 | 0.112 | 0.5 |
Echinococcus granulosus | inosine 5' monophosphate dehydrogenase 2 | 0.0134 | 0 | 0.5 |
Toxoplasma gondii | IMP dehydrogenas | 0.0134 | 0 | 0.5 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Trypanosoma brucei | GMP reductase | 0.0134 | 0 | 0.5 |
Brugia malayi | inosine-5'-monophosphate dehydrogenase family protein | 0.0134 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.6653 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0864 | 0.112 | 0.5 |
Leishmania major | inosine-5-monophosphate dehydrogenase | 0.0134 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.6653 | 1 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.6653 | 1 | 1 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0134 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0864 | 0.112 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of recombinant Cryptosporidium parvum IMPDH assessed as production of NADH by fluorescence assay in presence of 0.05% BSA | ChEMBL. | 23324406 | |
IC50 (binding) | > 5000 nM | Inhibition of recombinant Cryptosporidium parvum IMPDH assessed as production of NADH by fluorescence assay | ChEMBL. | 23324406 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.